Medizinische Universität Graz, Klin. Abteilung für Orale Chirurgie und Kieferorthopädie
Graz, 8010, Austria
NCT Number: NCT05142449
59 medically healthy patients, who are scheduled for third molar extraction surgery and give informed consent for the trial, are operated using a split-mouth technique.
One group of patients will be assigned to the test group (Amoxilan) for the first surgery and to the control group (placebo) for the second surgery, and vice versa, according to randomisation.
Patients receive 8 capsules Amoxilan or placebo (according to randomisation) perioperatively, and 6 capsules Amoxilan/placebo per day for 3 days postoperativeley.
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Phase 4
Graz, 8010, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive 8 capsules Amoxilan perioperatively and for the next 3 days 6 capsules per day
Patients receive 8 capsules placebo perioperatively and for the next 3 days 6 capsules per day
Time frame: preoperatively as well as on the 1st and 7th postoperative day
Interincisal distance, with maximum mouth opening, is measured with a ruler.
Time frame: preoperatively as well as on the 1st and 7th postoperative day
Swelling in the cheek area will be determined using a tape measure and 3D photographs.
Time frame: day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery
Patients indicate bleeding symptoms on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome
Time frame: day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery
Patients indicate swelling on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome
Time frame: day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery
Patients indicate pain on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome
Medical University of Graz
Other
Effect of Systemic Antibiotic Therapy on Postoperative Complications in Patients Undergoing Wisdom Teeth Removal Surgery. A Double-blind, Randomised, Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07647419
Dental Anxiety, Neurologic Manifestations
Lima, Lima Province, Peru
View Trial DetailsNCT07436546
Impacted Third Molar, Impacted Third Molar Tooth
Rohtak, Haryana, India
View Trial DetailsNCT07296172
Satisfaction Survey, Third Molar Extraction Surgery
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06967246
Kinesiotaping, Nervous System Diseases
Ho Chi Minh City, Vietnam
View Trial Details